Know Cancer

or
forgot password

Anxiety in African-American Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an African-American Sample


N/A
18 Years
N/A
Open (Enrolling)
Male
Anxiety Disorder, Depression, Prostate Cancer

Thank you

Trial Information

Anxiety in African-American Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an African-American Sample


OBJECTIVES:

Primary

- To establish the psychometric properties of the Memorial Anxiety Scale for Prostate
Cancer (MAX-PC) in African American men with prostate cancer.

- To establish the reliability of the MAX-PC in African American men with prostate
cancer.

- To establish the validity of the MAX-PC in African American men with prostate cancer.

- To confirm the factor structure of the MAX-PC in this sample.

- To test the sensitivity to change of the MAX-PC in this sample.

Secondary

- To explore the prevalence of distress, anxiety, and depression in African American men
with prostate cancer.

OUTLINE: This is a multicenter study.

All patients complete a 5-minute Memorial Anxiety Scale for Prostate Cancer (MAX-PC)
questionnaire measuring general prostate cancer anxiety, PSA anxiety, and fear of recurrence
either in person or by phone. They will complete six other questionnaires, each requiring 5
minutes to complete, and focusing on anxiety, depression, and quality of life measures.
These include the demographic questionnaire; the Distress Thermometer visual analogue scale;
the Hospital Anxiety and Depression Scale (HADS); the Functional Assessment of Cancer
Therapy Scale-Prostate (FACT-P); the Center for Epidemiologic Studies Depression Scale
(CES-D) assessing the frequency of depressive symptoms the patient experienced in the past
week; and the Karnofsky Patient Performance Rating Scale (KPRS). Within 1 week after
receiving their PSA test results, some patients will undergo an additional telephone
interview conducted by a research study assistant to complete the MAX-PC, the HADS, and the
Distress Thermometer questionnaires.

PROJECTED ACCRUAL: A total of 150 patients (75 patients with early stage disease and 75
patients with late stage disease) will be accrued for this study.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Diagnosis of prostate cancer

- Early stage disease (T1or T2, N0, M0)

- Advanced stage disease meeting 1 of the following criteria:

- Locally advanced disease (T3 or T4, N0, M0)

- Metastatic disease (T3 or T4, N1-3 or M1a-c)

- Undergoing monitoring for prostate-specific antigen (PSA) levels

- Men who identify themselves as Black, African-American, or men of African descent and
non-Hispanic will be eligible for the study

- "Black, African American, or of African descent" will be defined as men having
origins in any black racial groups of Africa

- "Haitian" will be used in addition to "Black" or "African American" to help
clarify this group

- Men who identify themselves as Black and Hispanic are included

- "Hispanic" will be defined as a person of Mexican, Puerto Rican, Cuban,
South or Central American, or other Spanish culture or origin

- "Latino" and "Spanish origin" will be used in addition to "Hispanic" to
help clarify this group

- No other non-Black or non-African American ethnic groups

PATIENT CHARACTERISTICS:

- Able to comprehend and complete questionnaires in English

- No major psychopathology or cognitive impairment likely, in the judgment of the
research staff, to interfere with the participation or completion of the protocol

PRIOR CONCURRENT THERAPY:

- Not specified

Type of Study:

Observational

Study Design:

N/A

Outcome Measure:

Psychosocial measures

Safety Issue:

No

Principal Investigator

Christian J. Nelson, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

Unspecified

Study ID:

CDR0000572399

NCT ID:

NCT00602654

Start Date:

September 2007

Completion Date:

Related Keywords:

  • Anxiety Disorder
  • Depression
  • Prostate Cancer
  • depression
  • anxiety disorder
  • stage I prostate cancer
  • stage IIB prostate cancer
  • stage IIA prostate cancer
  • stage III prostate cancer
  • stage IV prostate cancer
  • recurrent prostate cancer
  • Anxiety Disorders
  • Depression
  • Depressive Disorder
  • Prostatic Neoplasms

Name

Location

Memorial Sloan-Kettering Cancer CenterNew York, New York  10021
Queens Cancer Center of Queens HospitalJamaica, New York  11432
SUNY Downstate Medical CenterBrooklyn, New York  11203
NYU Cancer Institute at New York University Medical CenterNew York, New York  10016
Kings County Hospital CenterBrooklyn, New York  11203